Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Expert Opinion on Pharmacotherapy|November 24, 2015
Carbidopa levodopa enteral suspensionLauren C Seeberger, Robert A HauserExpert Review of Neurotherapeutics|July 11, 2009
Levodopa/carbidopa/entacapone in Parkinson's diseaseLauren C Seeberger, Robert A HauserExpert Opinion on Pharmacotherapy|July 13, 2017
Valbenazine for the treatment of tardive dyskinesiaLauren C Seeberger, Robert A HauserNeuropharmacology|October 16, 2007
Optimizing bioavailability in the treatment of Parkinson's diseaseLauren C Seeberger, Robert A HauserNeurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|August 14, 2020
Complementary Therapies in Parkinson Disease: a Review of Acupuncture, Tai Chi, Qi Gong, Yoga, and CannabisLisa M Deuel, Lauren C SeebergerScience (New York, N.Y.)|November 6, 2004
By carrot or by stick: cognitive reinforcement learning in parkinsonismMichael J Frank, Lauren C Seeberger, Randall C O'reillyThe International Journal of Neuroscience|November 18, 2009
Movement disorders associated with aripiprazole use: a case seriesDeborah A Hall, Pinky Agarwal, Alida Griffith, et al.Journal of Parkinson'S Disease|August 14, 2013
Examination of the UPDRS bradykinesia subscale: equivalence, reliability and validityPhilip O Buck, Ronald E Wilson, Lauren C Seeberger, et al.Journal of Clinical and Experimental Neuropsychology|March 17, 2007
MS vs. HD: can white matter and subcortical gray matter pathology be distinguished neuropsychologically?Jose M Lafosse, John R Corboy, Maureen A Leehey, et al.The Neurologist|November 3, 2011
Rasagiline: time to onset of antiparkinson effect is similar when used as a monotherapy or adjunct treatmentRonald E Wilson, Lauren C Seeberger, Dee Silver, et al.Pageof 2